NDC 0078-0953 Tobradex
Tobramycin And Dexamethasone Suspension/ Drops Ophthalmic

Product Information

What is NDC 0078-0953?

The NDC code 0078-0953 is assigned by the FDA to the product Tobradex which is a human prescription drug product labeled by Novartis Pharmaceuticals Corporation. The generic name of Tobradex is tobramycin and dexamethasone. The product's dosage form is suspension/ drops and is administered via ophthalmic form. The product is distributed in 3 packages with assigned NDC codes 0078-0953-25 5 ml in 1 bottle , 0078-0953-26 10 ml in 1 bottle , 0078-0953-40 2.5 ml in 1 bottle . This page includes all the important details about this product, including active and inactive ingredients, pharmagologic classes, product uses and characteristics, UNII information, RxNorm crosswalk and the complete product label.

NDC Product Code0078-0953
Proprietary Name What is the Proprietary Name?
The proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.		Tobradex
Non-Proprietary Name What is the Non-Proprietary Name?
The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.		Tobramycin And Dexamethasone
Product Type What kind of product is this?
Indicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.		Human Prescription Drug
Dosage FormSuspension/ Drops - A suspension which is usually administered in a dropwise fashion.
Administration Route(s) What are the Administration Route(s)?
The translation of the route code submitted by the firm, indicating route of administration.
  • Ophthalmic - Administration to the external eye.
Product Labeler Information What is the Labeler Name?
Name of Company corresponding to the labeler code segment of the Product NDC.		Novartis Pharmaceuticals Corporation
Labeler Code0078
FDA Application Number What is the FDA Application Number?
This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.		NDA050592
Marketing Category What is the Marketing Category?
Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.		NDA - A product marketed under an approved New Drug Application.
Start Marketing Date What is the Start Marketing Date?
This is the date that the labeler indicates was the start of its marketing of the drug product.		09-15-1988
Listing Expiration Date What is the Listing Expiration Date?
This is the date when the listing record will expire if not updated or certified by the product labeler.		12-31-2023
Exclude Flag What is the NDC Exclude Flag?
This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions ("Y"), or because the listing certification is expired ("E"), or because the listing data was inactivated by FDA ("I"). Values = "Y", "N", "E", or "I". 		N
NDC Code Structure

What are the uses for Tobradex?


Product Packages

NDC Code 0078-0953-25

Package Description: 5 mL in 1 BOTTLE

Price per Unit: $35.24573 per ML

NDC Code 0078-0953-26

Package Description: 10 mL in 1 BOTTLE

NDC Code 0078-0953-40

Package Description: 2.5 mL in 1 BOTTLE

Product Details

What are Tobradex Active Ingredients?

An active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
  • DEXAMETHASONE 1 mg/mL - An anti-inflammatory 9-fluoro-glucocorticoid.
  • TOBRAMYCIN 3 mg/mL - An aminoglycoside, broad-spectrum antibiotic produced by Streptomyces tenebrarius. It is effective against gram-negative bacteria, especially the PSEUDOMONAS species. It is a 10% component of the antibiotic complex, NEBRAMYCIN, produced by the same species.

Tobradex Active Ingredients UNII Codes

NDC to RxNorm Crosswalk

What is RxNorm? RxNorm is a normalized naming system for generic and branded drugs that assigns unique concept identifier(s) known as RxCUIs to NDC products.The NDC to RxNorm Crosswalk for this produdct indicates multiple concept unique identifiers (RXCUIs) are associated with this product:
  • RxCUI: 208813 - TobraDex 0.3 % / 0.1 % Ophthalmic Suspension
  • RxCUI: 208813 - dexamethasone 1 MG/ML / tobramycin 3 MG/ML Ophthalmic Suspension [Tobradex]
  • RxCUI: 208813 - TobraDex (dexamethasone 0.1 % / tobramycin 0.3 % ) Ophthalmic Suspension
  • RxCUI: 309683 - tobramycin 0.3 % / dexamethasone 0.1 % Ophthalmic Suspension
  • RxCUI: 309683 - dexamethasone 1 MG/ML / tobramycin 3 MG/ML Ophthalmic Suspension

Tobradex Inactive Ingredients UNII Codes

The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product.

Pharmacologic Class(es)

A pharmacologic class is a group of drugs that share the same scientifically documented properties. The following is a list of the reported pharmacologic class(es) corresponding to the active ingredients of this product.

* Please review the disclaimer below.

Tobradex Product Label

FDA filings in the form of structured product labels are documents that include all published material associated whith this product. Product label information includes data like indications and usage generic names, contraindications, active ingredients, strength dosage, routes of administration, appearance, usage, warnings, inactive ingredients, etc.

Product Label Table of Contents



Principal Display Panel



NDC 0078-0953-25

TobraDex®

(tobramycin and
dexamethasone
ophthalmic
suspension, USP)
0.3%/0.1%

FOR TOPICAL OPHTHALMIC USE

5 mL

Sterile

NOVARTIS

PRINCIPAL DISPLAY PANEL 0078-0953-25 TobraDex® (tobramycin and dexamethasone ophthalmic suspension, USP) 0.3%/0.1% FOR TOPICAL OPHTHALMIC USE 5 mL Sterile NOVARTIS - carton

PRINCIPAL DISPLAY PANEL 0078-0953-25 TobraDex® (tobramycin and dexamethasone ophthalmic suspension, USP) 0.3%/0.1% FOR TOPICAL OPHTHALMIC USE 5 mL Sterile NOVARTIS - carton


* Please review the disclaimer below.